Supplemental Financial Schedules May 19, 2015

Size: px
Start display at page:

Download "Supplemental Financial Schedules May 19, 2015"

Transcription

1 Supplemental Financial Schedules May 19, 2015

2 The presentations and related schedules contain financial measures that are not calculated in accordance with generally accepted accounting principles (GAAP). The non-gaap financial measures include adjusted operating margin, adjusted EBITDA margin, and free cash flow. Non-GAAP financial measures may provide a more complete understanding of Baxalta s operations and can facilitate a fuller analysis of Baxalta s results of operations, particularly in evaluating performance from one period to another. Baxalta has presented adjusted operating margin which excludes interest and other expense and intangible asset amortization and adjusted EBITDA margin which, in addition to the previous adjustments, also excludes depreciation. Additionally, adjusted operating margin and adjusted EBITDA margin exclude the impact of special items, which are excluded because they are highly variable, difficult to predict, and of a size that may substantially impact Baxalta s operations and can facilitate a fuller analysis of Baxalta s results of operations, particularly in evaluating performance from one period to another. Upfront and milestone payments related to collaborative arrangements that have been expensed as research and development (R&D) are uncertain and often result in a different payment and expense recognition pattern than internal R&D activities and therefore are typically excluded as special items. Intangible asset amortization is excluded to facilitate an evaluation of current and past operating performance, particularly in terms of cash returns, and is similar to how management internally assesses performance. Management believes that non-gaap earnings measures, when used in conjunction with the results presented in accordance with GAAP and the reconciliations to corresponding GAAP financial measures, may enhance an investor s overall understanding of Baxalta s past financial performance and prospects for the future. Accordingly, management uses these non-gaap measures internally in financial planning, to monitor business unit performance, and in some cases for purposes of determining incentive compensation. Baxalta strongly encourages investors to review its consolidated financial statements and publicly filed reports in their entirety and cautions investors that the non-gaap measures used by Baxalta may differ from similar measures used by other companies, even when similar terms are used to identify such measures.

3 *Excludes MSA revenues of ~$150 million which will be recorded going forward in the BioTherapeutics product category Reported Sales 2012 Sales ($M) 2013 Sales ($M) 2014 Sales ($M) U.S. Int l Total U.S. Int l Total U.S. Int l Total Hemophilia $1,141 $1,486 $2,627 $1,216 $1,570 $2,786 $1,281 $1,703 $2,984 Inhibitors Hematology $1,320 $1,921 $3,241 $1,410 $2,027 $3,437 $1,500 $2,228 $3,728 Immunoglobulin $1,161 $422 $1,583 $1,228 $388 $1,616 $1,272 $405 $1,677 BioTherapeutics Immunology $1,367 $702 $2,069 $1,451 $667 $2,118 $1,516 $708 $2,224 Total* $2,687 $2,623 $5,310 $2,861 $2,694 $5,555 $3,016 $2,936 $5,952

4 *Excludes MSA revenues of ~$150 million which will be recorded going forward in the BioTherapeutics product category Reported Sales Growth 2014 Reported Growth 2014 Constant Currency U.S. Int l Total U.S. Int l Total Hemophilia 5% 8% 7% 5% 11% 8% Inhibitors 13% 15% 14% 13% 16% 15% Hematology 6% 10% 8% 6% 12% 10% Immunoglobulin 4% 4% 4% 4% 7% 5% BioTherapeutics 9% 9% 9% 9% 10% 10% Immunology 4% 6% 5% 4% 9% 6% Total* 5% 9% 7% 5% 11% 8% 2013 Reported Growth 2013 Constant Currency U.S. Int l Total U.S. Int l Total Hemophilia 7% 6% 6% 7% 7% 7% Inhibitors 8% 5% 6% 8% 7% 7% Hematology 7% 6% 6% 7% 7% 7% Immunoglobulin 6% -8% 2% 6% -8% 2% BioTherapeutics 8% 0% 3% 8% -1% 3% Immunology 6% -5% 2% 6% -5% 2% Total* 6% 3% 5% 6% 3% 5%

5 *Income from continuing operations excludes Vaccines **Refer to most recently filed Form 10 for reconciliation of 2014 GAAP P&L to 2014 Pro Forma P&L. FY 2014 Pro Forma results subject to change in future Form 10 filings based on final pro forma adjustments Historical Financial Summary (GAAP) ($ Millions) Pro Forma 2014** Net Sales $6,109 $5,952 $5,555 $5,310 Growth YoY 10% 7% 5% N/A Cost of Sales (2,590) (2,443) (2,329) (2,240) Gross Margin 3,519 3,509 3,226 3,070 % of Net Sales 58% 59% 58% 58% SG&A 1,020 1,053 1, R&D Interest & Other Pre-Tax Income* $1,577 $1,532 $1,613 $1,561 Source: Form 10 filing - May 19, 2015

6 *Income from continuing operations excludes Vaccines **Refer to most recently filed Form 10 for reconciliation of 2014 GAAP P&L to 2014 Pro Forma P&L. Adjusted Pro Forma financial information excludes special items, refer to the Reconciliation of GAAP Pre-tax Income to Adjusted Pre-tax Income for additional information. FY 2014 Pro Forma results subject to change in future Form 10 filings based on final pro forma adjustments Historical Financial Summary (Adjusted) ($ Millions) Pro Forma 2014** Net Sales $6,109 $5,952 $5,555 $5,310 Growth YoY 10% 7% 5% N/A Cost of Sales (2,573) (2,426) (2,308) (2,205) Gross Margin 3,536 3,526 3,247 3,105 % of Net Sales 58% 59% 58% 58% SG&A R&D Interest & Other (65) (65) (17) 15 Pre-Tax Income* $2,073 $2,028 $1,862 $1,813 Additional Non-GAAP Measures: Adjusted Operating Income $2,008 $1,963 $1,845 $1,828 % of Net Sales 33% 33% 33% 34% Adjusted EBITDA $2,205 $2,150 $2,005 $1,971 % of Net Sales 36% 36% 36% 37% Source: Form 10 filing - May 19, 2015

7 *Refer to Reconciliation of GAAP Pre-tax Income to Adjusted Pre-tax Income for additional information **Refer to most recently filed Form 10 for reconciliation of 2014 GAAP P&L to 2014 Pro Forma P&L. FY 2014 Pro Forma results subject to change in future Form 10 filings based on final pro forma adjustments ***Baxalta has also presented guidance for H2 2015, 2016 and 2020 using non-gaap measures of adjusted operating income margin and adjusted EBITDA margin. Baxalta projects that GAAP pre-tax income margin would be lower than adjusted operating income margin by 2% for each period presented, with reconciling items of interest expense and intangible asset amortization expense. GAAP pre-tax income margin would be lower than adjusted EBITDA margin by an additional 4% in H and 5% in both 2016 and 2020 related to depreciation expense. Additionally, Baxalta presents guidance for the non-gaap measure of free cash flows for 2016 and 2020, which represents GAAP operating cash flows less projected capital expenditures of approximately $0.9B and approximately $0.8B, respectively Non-GAAP Reconciliation Operating Income And EBITDA ($ Millions) Pro Forma FY 2014** FY 2014 FY 2013 FY 2012 Pre-tax Income $1,577 $1,532 $1,613 $1,561 Adjustments for special items* Adjusted Pre-tax Income $2,073 $2,028 $1,862 $1,813 Remove: Interest and Other (65) (65) (17) 15 Adjusted Operating Income*** $2,008 $1,963 $1,845 $1,828 % of Net Sales 33% 33% 33% 34% Remove: Depreciation Adjusted EBITDA*** $2,205 $2,150 $2,005 $1,971 % of Net Sales 36% 36% 36% 37% Source: Form 10 filing - May 19, 2015

8 *Refer to most recently filed Form 10 for reconciliation of 2014 GAAP P&L to 2014 Pro Forma P&L. FY 2014 Pro Forma results subject to change in future Form 10 filings based on final pro forma adjustments Reconciliation Of GAAP Pre-tax Income To Adjusted Pre-tax Income ($ Millions) Pro Forma FY 2014** FY 2014 FY 2013 FY 2012 Pre-tax income $1,577 $1,532 $1,613 $1,561 Adjustments for special items Upfront and milestone payments to collaboration partners Business optimization items Change in fair value of contingent payment liabilities Other-than-temporary impairment charge Branded Prescription Drug Fee Separation costs Intangible asset amortization expense Plasma-related litigation (10) (10) 84 - Turkey VAT charge Pension settlement charge allocated from Baxter Total special items $496 $496 $249 $252 Adjusted pre-tax income $2,073 $2,028 $1,862 $1,813 Source: Form 10 filing - May 19, 2015

9 *Refer to most recently filed Form 10 for reconciliation of 2014 GAAP P&L to 2014 Pro Forma P&L. FY 2014 Pro Forma results subject to change in future Form 10 filings based on final pro forma adjustments Reconciliation Of GAAP P&L Line Items To Adjusted P&L Line Items ($ Millions) Pro Forma FY 2014** FY 2014 FY 2013 FY 2012 Gross Margin $3,519 $3,509 $3,226 $3,070 Intangible asset amortization expense Business optimization items Adjusted Gross Margin $3,536 $3,526 $3,247 $3,105 % of Net Sales 58% 59% 58% 58% SG&A $1,020 $1,053 $1,017 $913 Business optimization items - - (16) (16) Branded Prescription Drug Fee (26) (26) - - Separation costs (43) (43) - - Plasma-related litigation (84) - Pension settlement charge (72) Turkey VAT charge - - (8) - Adjusted SG&A $961 $994 $909 $825 R&D $818 $820 $595 $581 Upfront and milestone payments to collaboration partners (217) (217) (78) (113) Business optimization items (21) (21) (24) (16) Separation costs (13) (13) - - Adjusted R&D $567 $569 $493 $452 Interest & Other Expense (Income) $104 $104 $1 $15 Change in fair value of contingent payment liabilities (124) (124) (18) - Other-than-temporary imparment charge (45) (45) - - Adjusted Interest & Other Expense (Income) ($65) ($65) ($17) $15 Source: Form 10 filing - May 19, 2015

10 Safe Harbor Statement The presentations these schedules support contain forward-looking statements concerning the planned separation of Baxter s biopharmaceutical and medical products businesses and the expected business prospects, long range plan, capital structure, R&D pipeline including regulatory actions and commercial launch events, business development plans and other growth strategies of the two resulting companies after the separation. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand for and market acceptance of risks for new and existing products; product development risks; product quality or patient safety concerns; future actions of regulatory bodies and other governmental authorities, including the FDA and foreign counterparts; failures with respect to compliance programs; future actions of third-parties, including payers; U.S. healthcare reform and other global austerity measures; pricing, reimbursement, taxation and rebate policies of government agencies and private payers; the impact of competitive products and pricing, including generic competition, drug reimportation and disruptive technologies; global, trade and tax policies; accurate identification of and execution on business development and R&D opportunities and realization of anticipated benefits; fluctuations in supply and demand and the pricing of plasma-based therapies; the availability of acceptable raw materials and component supply; the inability to create timely production capacity or other manufacturing supply difficulties; the ability to successfully separate the biopharmaceutical and medical products businesses on the terms or timeline currently contemplated, if at all, and achieve the intended results; the ability to enforce owned or in-licensed patents or the patents of third-parties preventing or restricting manufacture, sale or use of affected products or technology; the impact of global economic conditions; fluctuations in foreign exchange and interest rates; any change in law concerning the taxation of income, including income earned outside the United States; actions taken by tax authorities in connection with ongoing tax audits; breaches or failures of the company s information technology systems; loss of key employees or inability to identify and recruit new employees; the outcome of pending or future litigation; the adequacy of the company s cash flows from operations to meet its ongoing cash obligations and fund its investment program; and other risks identified in the Form 10 filed by Baxalta Incorporated and Baxter s most recent filing on Form 10-K and other Securities and Exchange Commission filings, all of which are available on Baxter s website. Baxter does not undertake to update its forward-looking statements. These schedules and the related presentations are also included on Baxter s website.

MEDICATION DELIVERY. David Ferguson GM, Medication Delivery. May 21, 2018

MEDICATION DELIVERY. David Ferguson GM, Medication Delivery. May 21, 2018 MEDICATION DELIVERY David Ferguson GM, Medication Delivery May 21, 2018 Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter s financial results, R&D pipeline,

More information

General Employment Announces Results for Fiscal 2015 Fourth Quarter and Year End

General Employment Announces Results for Fiscal 2015 Fourth Quarter and Year End December 30, 2015 General Employment Announces Results for Fiscal 2015 Fourth Quarter and Year End Company Provides Combined Select Pro Forma Financial Information NAPERVILLE, IL -- (Marketwired) -- 12/30/15

More information

Third Quarter Fiscal 2013 Performance June 29, Financial results and company highlights Fourth quarter and fiscal year 2013 outlook

Third Quarter Fiscal 2013 Performance June 29, Financial results and company highlights Fourth quarter and fiscal year 2013 outlook Third Quarter Fiscal 2013 Performance June 29, 2013 Financial results and company highlights Fourth quarter and fiscal year 2013 outlook Safe Harbor Statement This presentation contains forward looking

More information

Energy Aerospace & Defense Industrial. First Quarter Investor Review

Energy Aerospace & Defense Industrial. First Quarter Investor Review Energy Aerospace & Defense Industrial First Quarter 2018 Investor Review Presented May 2, 2018 1 Safe Harbor This presentation contains forward-looking statements within the meaning of Section 27 A of

More information

Q Earnings Presentation. July 18 th, 2014

Q Earnings Presentation. July 18 th, 2014 Q2 2014 Earnings Presentation July 18 th, 2014 The SAFE HARBOR Statement under the Private Securities Litigation Reform Act of 1995 Statements included in this announcement that are not historical facts

More information

Mylan. Raymond James 40 th Annual Institutional Investors Conference March 05, 2019

Mylan. Raymond James 40 th Annual Institutional Investors Conference March 05, 2019 Mylan Raymond James 40 th Annual Institutional Investors Conference March 05, 2019 Forward-Looking Statements This presentation contains forward-looking statements. These statements are made pursuant to

More information

PerkinElmer Announces Financial Results for the First Quarter 2008

PerkinElmer Announces Financial Results for the First Quarter 2008 PerkinElmer Announces Financial Results for the First Quarter 2008 -- Revenue of $482 million, up 20% over the prior year -- EPS from continuing operations of $0.20; Adjusted EPS of $0.29, up 21% over

More information

Investment Community Conference Call. First Quarter, 2017 Earnings May 4, 2017

Investment Community Conference Call. First Quarter, 2017 Earnings May 4, 2017 Investment Community Conference Call First Quarter, 2017 Earnings May 4, 2017 Use of Non-GAAP Financial Information Diebold Nixdorf has included non-gaap financial measures in this presentation to supplement

More information

Extreme Networks FQ2 18 Financial Results

Extreme Networks FQ2 18 Financial Results Extreme Networks FQ2 18 Financial Results February 6, 2018 Cautionary Statement on Financial Measures Non-GAAP Measures: In preparing the accompanying information, the Company has excluded, where applicable,

More information

CISCO SYSTEMS, INC. Q4 FY 2004 CONFERENCE CALL

CISCO SYSTEMS, INC. Q4 FY 2004 CONFERENCE CALL CISCO SYSTEMS, INC. Q4 FY 2004 CONFERENCE CALL August 10, 2004 2004, Cisco Systems, Inc. All rights reserved. 1 GAAP Reconciliation and Forward-Looking Statements GAAP RECONCILIATION During this presentation

More information

CISCO SYSTEMS, INC. Q4 FY 2005 CONFERENCE CALL

CISCO SYSTEMS, INC. Q4 FY 2005 CONFERENCE CALL CISCO SYSTEMS, INC. Q4 FY 2005 CONFERENCE CALL August 9, 2005 2005, Cisco Systems, Inc. All rights reserved. 1 GAAP Reconciliation and Forward-Looking Statements GAAP RECONCILIATION During this presentation

More information

Telenav Reports Second Quarter Fiscal 2017 Financial Results

Telenav Reports Second Quarter Fiscal 2017 Financial Results January 31, 2017 Telenav Reports Second Quarter Fiscal 2017 Financial Results SANTA CLARA, Calif., Jan. 31, 2017 (GLOBE NEWSWIRE) -- Telenav, Inc. (NASDAQ:TNAV), a leader in connected car services, today

More information

Extreme Networks FQ1 19 Financial Results

Extreme Networks FQ1 19 Financial Results Extreme Networks FQ1 19 Financial Results November 2, 2018 Cautionary Statement on Financial Measures Non-GAAP Measures: In preparing the accompanying information, the Company has excluded, where applicable,

More information

Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference. Kåre Schultz President and CEO January 7, 2019

Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference. Kåre Schultz President and CEO January 7, 2019 Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference Kåre Schultz President and CEO January 7, 2019 Cautionary Note Regarding Forward-Looking Statements 2 This presentation contains forward-looking

More information

May 1, 2017 Q FINANCIAL FLASH

May 1, 2017 Q FINANCIAL FLASH May 1, 2017 Q1 2017 FINANCIAL FLASH DISCLAIMER The following information is preliminary financial information only. The Company has not yet finalized the fresh start accounting process. Material changes

More information

VeriFone Files Restated Reports

VeriFone Files Restated Reports VeriFone Files Restated Reports SAN JOSE, Calif. -- August 19, 2008 --VeriFone Holdings Inc. (NYSE: PAY) today filed its amended and restated quarterly report on Form 10-Q/A for the fiscal quarters ended

More information

Innovative technology. Winning strategy. Delivering value.

Innovative technology. Winning strategy. Delivering value. Better Lives. Better Planet.SM Innovative technology. Winning strategy. Delivering value. Larry Kingsley Chairman & CEO, Pall Corporation RW Baird Industrial Conference November 11, 2014 2014 Pall Corporation

More information

STRATASYS Q May 9 th, 2016 FINANCIAL RESULTS CONFERENCE CALL 1 STRATASYS / THE 3D PRINTING SOLUTIONS COMPANY

STRATASYS Q May 9 th, 2016 FINANCIAL RESULTS CONFERENCE CALL 1 STRATASYS / THE 3D PRINTING SOLUTIONS COMPANY STRATASYS Q1 2016 FINANCIAL RESULTS CONFERENCE CALL May 9 th, 2016 1 STRATASYS / THE 3D PRINTING SOLUTIONS COMPANY Q1 2016 Conference and webcast details Speakers David Reis CEO Erez Simha COO & CFO Shane

More information

Changes to non-gaap Financial Reporting for Silver Spring Networks FAQ. February 10, 2017

Changes to non-gaap Financial Reporting for Silver Spring Networks FAQ. February 10, 2017 Changes to non-gaap Financial Reporting for Silver Spring Networks FAQ February 10, 2017 On May 17, 2016, the Staff of the United States Securities and Exchange Commission (the SEC ) updated their Compliance

More information

WINDSTREAM CORPORATION UNAUDITED CONSOLIDATED STATEMENTS OF INCOME (In millions, except per share amounts)

WINDSTREAM CORPORATION UNAUDITED CONSOLIDATED STATEMENTS OF INCOME (In millions, except per share amounts) (A) (B) (C) (D) WINDSTREAM CORPORATION UNAUDITED CONSOLIDATED STATEMENTS OF INCOME (In millions, except per share amounts) THREE MONTHS ENDED SIX MONTHS ENDED Increase Increase June 30, June 30, (Decrease)

More information

Extreme Networks FQ4 17 Financial Results

Extreme Networks FQ4 17 Financial Results Extreme Networks FQ4 17 Financial Results August 14, 2017 Cautionary Statement on Financial Measures Non-GAAP Measures: In preparing the accompanying information, the Company has excluded, where applicable,

More information

Investor Slides. Needham 20 th Annual Growth Conference January 17, 2018 NASDAQ GS: UEIC

Investor Slides. Needham 20 th Annual Growth Conference January 17, 2018 NASDAQ GS: UEIC Investor Slides Needham 20 th Annual Growth Conference January 17, 2018 NASDAQ GS: UEIC Safe Harbor Statement During this presentation, Management will reference Adjusted Non-GAAP information, including

More information

Jefferies TMT Conference

Jefferies TMT Conference Jefferies TMT Conference Tarek Sherif, Chairman and CEO Cory Douglas, CFO May 9, 2013 2013 Medidata Solutions, Inc. 1 Safe Harbor Statement This presentation contains forward-looking statements within

More information

Morgan Stanley Conference. November 15, 2017

Morgan Stanley Conference. November 15, 2017 Morgan Stanley Conference November 15, 2017 1 Forward Looking Statements Certain statements in this release or presentation, other than purely historical information, including estimates, projections,

More information

Reconciliations of Non GAAP Financial Measures. For the Three and Six Months Ended December 31, 2012 and 2011

Reconciliations of Non GAAP Financial Measures. For the Three and Six Months Ended December 31, 2012 and 2011 Reconciliations of Non GAAP Financial Measures For the Three and Six Months Ended December 31, 2012 and 2011 1 Non GAAP Metrics Disclosure The Company believes that providing both GAAP and adjusted non

More information

FORTUNE BRANDS HOME & SECURITY, INC. ADJUSTED PRO FORMA INFORMATION (In millions, except per share amounts) (Unaudited)

FORTUNE BRANDS HOME & SECURITY, INC. ADJUSTED PRO FORMA INFORMATION (In millions, except per share amounts) (Unaudited) ADJUSTED PRO FORMA INFORMATION (In millions, except per share amounts) Three Months Ended December 31, Year Ended December 31, 2011 2010 % Change 2011 2010 % Change Net Sales (GAAP) Kitchen & Bath Cabinetry

More information

Fourt r h t Q u Q art ar er Fiscal scal Y ear ear 2011 Fin i ancial ci al Result l s

Fourt r h t Q u Q art ar er Fiscal scal Y ear ear 2011 Fin i ancial ci al Result l s Fourth Quarter Fiscal Year 2011 Financial Results June 9, 2011 1 Forward Looking Statements Certain statements included in this management presentation constitute forward-looking statements, including

More information

THERMO FISHER SCIENTIFIC

THERMO FISHER SCIENTIFIC THERMO FISHER SCIENTIFIC February 8, 2007 Reconciliation of Financial Information Q4-2006 1. GAAP P&L (as reported): 2002 to 2006 2. Reconciliation of GAAP to Adjusted P&L: 2002 to 2006 3. Business Segment

More information

First Quarter 2017 Earnings. May 9, 2017

First Quarter 2017 Earnings. May 9, 2017 First Quarter 2017 Earnings May 9, 2017 1 Safe Harbor Caution Concerning Forward-Looking Statements Various remarks that the Company makes contain forward-looking statements regarding acquisitions, acquisition

More information

2018 Annual Meeting of Stockholders. May 8, 2018

2018 Annual Meeting of Stockholders. May 8, 2018 2018 Annual Meeting of Stockholders May 8, 2018 2018 Annual Meeting of Stockholders? Introductions and Meeting Procedures 2018 Annual Meeting Proposals Baxter Overview Voting Results Questions and Answers

More information

GOLDMAN SACHS GLOBAL HEALTHCARE CONFERENCE June 14, 2017

GOLDMAN SACHS GLOBAL HEALTHCARE CONFERENCE June 14, 2017 GOLDMAN SACHS GLOBAL HEALTHCARE CONFERENCE June 14, 2017 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments

More information

Disclaimer Forward-Looking Statements Industry and Market Data Non-GAAP Financial Information

Disclaimer Forward-Looking Statements Industry and Market Data Non-GAAP Financial Information Disclaimer Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the Securities Act of 1933, as amended (the Securities Act ), the Securities Exchange Act

More information

EMEA MARKET MARKETING HEIDI ARKINSTALL CMO. RENE OEHLERKING Jaybird. UJESH DESAI GM, Gaming

EMEA MARKET MARKETING HEIDI ARKINSTALL CMO. RENE OEHLERKING Jaybird. UJESH DESAI GM, Gaming EMEA MARKET MARKETING HEIDI ARKINSTALL CMO RENE OEHLERKING Jaybird UJESH DESAI GM, Gaming FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of the U.S.

More information

Calix Q Financial Results. February 13, 2018

Calix Q Financial Results. February 13, 2018 Calix Q4 2017 Financial Results February 13, 2018 Safe Harbor This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements

More information

Supplemental Schedules for Q1-18 Earnings Release

Supplemental Schedules for Q1-18 Earnings Release Supplemental Schedules for Q1-18 Earnings Release April 4, 2018 Schedule 1 Q1 2018 Homebuilding Metrics, as Reported and Pro Forma Exhibit 99.2 Lennar Standalone (12/1/17-2/28/18) CalAtlantic (2/13/18-2/28/18)

More information

Munksjö historical. Ahlstrom- Munksjö Net sales Other operating income Total income

Munksjö historical. Ahlstrom- Munksjö Net sales Other operating income Total income 1 APPENDIX: UNAUDITED PRO FORMA FINANCIAL INFORMATION The following unaudited pro forma consolidated financial information (the Pro forma financial information ) is presented for illustrative purposes

More information

Fiscal 2018 Fourth Quarter Earnings Call April 10, 2019

Fiscal 2018 Fourth Quarter Earnings Call April 10, 2019 Fiscal 2018 Fourth Quarter Earnings Call April 10, 2019 Forward Looking Statements This presentation may contain forward-looking statements, including, but not limited to, anticipated net earnings per

More information

AmerisourceBergen. J.P. Morgan Healthcare Conference. Steve Collis, Chairman, President & CEO Tim Guttman, EVP & CFO.

AmerisourceBergen. J.P. Morgan Healthcare Conference. Steve Collis, Chairman, President & CEO Tim Guttman, EVP & CFO. AmerisourceBergen J.P. Morgan Healthcare Conference Steve Collis, Chairman, President & CEO Tim Guttman, EVP & CFO January 10, 2017 Cautionary Note Regarding Forward-Looking Statements Certain of the statements

More information

IBM 4Q 2016 Earnings. January 19, ibm.com/investor

IBM 4Q 2016 Earnings. January 19, ibm.com/investor IBM 4Q 2016 Earnings January 19, 2017 ibm.com/investor Forward Looking Statements and Non-GAAP Information 2 Certain comments made in this presentation may be characterized as forward looking under the

More information

2018 Q1 Investor Relations Presentation

2018 Q1 Investor Relations Presentation 2018 Q1 Investor Relations Presentation Forward Looking Statements This presentation contains forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events

More information

THOMSON REUTERS FIRST-QUARTER 2008 MAY 1, 2008

THOMSON REUTERS FIRST-QUARTER 2008 MAY 1, 2008 THOMSON REUTERS FIRST-QUARTER 2008 MAY 1, 2008 AGENDA WELCOME / INTRODUCTION FRANK GOLDEN STRATEGY / DRIVING RESULTS TOM GLOCER FINANCIAL REVIEW & 2008 OUTLOOK BOB DALEO Q & A 2 SPECIAL NOTE Safe Harbor

More information

May 10, 2018 Q EARNINGS CALL

May 10, 2018 Q EARNINGS CALL May 10, 2018 Q1 2018 EARNINGS CALL DISCLAIMER The following information is preliminary financial information only. None of the information has been reviewed or audited by our independent certified public

More information

West Pharmaceutical Services, Inc. J.P. Morgan Healthcare Conference. Eric M. Green, President & CEO January 9, 2019

West Pharmaceutical Services, Inc. J.P. Morgan Healthcare Conference. Eric M. Green, President & CEO January 9, 2019 West Pharmaceutical Services, Inc. J.P. Morgan Healthcare Conference Eric M. Green, President & CEO January 9, 2019 Safe Harbor Statement Cautionary Statement Under the Private Securities Litigation Reform

More information

Storing, Protecting and Connecting a Digital World. Investing in the Future

Storing, Protecting and Connecting a Digital World. Investing in the Future Storing, Protecting and Connecting a Digital World Investing in the Future February 1, 2011 Risks and Uncertainties Certain information contained in this press release which does not relate to historical

More information

Progress Software Reports 2010 Second Quarter Results

Progress Software Reports 2010 Second Quarter Results June 22, 2010 Progress Software Reports 2010 Second Quarter Results Non-GAAP Total Revenue Up 9%; Non-GAAP Earnings per Share Up 51%; Enterprise Business Solutions Revenue Up 39% BEDFORD, MA, Jun 22, 2010

More information

UBS Best of Americas Conference

UBS Best of Americas Conference The world leader in serving science UBS Best of Americas Conference Marijn E. Dekkers President and Chief Executive Officer September 21, 2007 Safe Harbor / Non-GAAP Measures Various remarks that we may

More information

WALGREEN CO FORM 8-K. (Current report filing) Filed 09/16/14 for the Period Ending 09/16/14

WALGREEN CO FORM 8-K. (Current report filing) Filed 09/16/14 for the Period Ending 09/16/14 WALGREEN CO FORM 8-K (Current report filing) Filed 09/16/14 for the Period Ending 09/16/14 Address 108 WILMOT RD DEERFIELD, IL 60015 Telephone 8479402500 CIK 0000104207 Symbol WAG SIC Code 5912 - Drug

More information

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World EnPro Industries Investor Presentation Engineered Products for a Demanding and Safer World Q1 2018 1 Forward-Looking Statements Statements in presentation that express a belief, expectation or intention,

More information

Q1 FY19 Financial Update

Q1 FY19 Financial Update Q FY9 Financial Update Salesforce NYSE: CRM @Salesforce_ir Safe Harbor "Safe harbor" statement under the Private Securities Litigation Reform Act of 995: This presentation contains forward-looking statements

More information

RECONCILIATION IFRS-US GAAP 2015 BEYOND THE LAYERS

RECONCILIATION IFRS-US GAAP 2015 BEYOND THE LAYERS RECONCILIATION IFRS-US GAAP 2015 BEYOND THE LAYERS ASMI STATUTORY ANNUAL REPORT 2015 Reconciliation ASMI s financial key figures based on IFRS and US GAAP 1 RECONCILIATION ASMI S FINANCIAL KEY FIGURES

More information

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World EnPro Industries Investor Presentation Engineered Products for a Demanding and Safer World Q2 2018 1 Forward-Looking Statements Statements in presentation that express a belief, expectation or intention,

More information

Precision Engineered Products Acquisition August 17, 2015

Precision Engineered Products Acquisition August 17, 2015 Precision Engineered Products Acquisition August 17, 2015 Forward-Looking Statements and Non-GAAP Financial Information Forward Looking Statements: With the exception of the historical information contained

More information

Investor Presentation

Investor Presentation Investor Presentation June 2018 Safe Harbor Statement All statements, other than statements of historical fact included in this presentation, are forward-looking statements. When used in this presentation,

More information

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World

EnPro Industries Investor Presentation. Engineered Products for a Demanding and Safer World EnPro Industries Investor Presentation Engineered Products for a Demanding and Safer World Q3 2018 1 Forward-Looking Statements Statements in this presentation that express a belief, expectation or intention,

More information

OpenText Buys EasyLink Reports Third Quarter Fiscal Year 2012 Financial Results

OpenText Buys EasyLink Reports Third Quarter Fiscal Year 2012 Financial Results PRESS RELEASE OpenText Buys EasyLink Reports Third Quarter Fiscal Year 2012 Financial Results Waterloo, ON, May 1, 2012 - Open Text (TM) Corporation (NASDAQ:OTEX) (TSX: OTC), announced today that is has

More information

Acquisition of Vtesse Inc. Increased Focus on Orphan and Pediatric Diseases

Acquisition of Vtesse Inc. Increased Focus on Orphan and Pediatric Diseases Acquisition of Vtesse Inc. Increased Focus on Orphan and Pediatric Diseases 1 Forward Looking Statement This presentation contains "forward-looking statements" as that term is defined in the Private Securities

More information

BlueLinx Second Quarter 2018 Earnings Webcast

BlueLinx Second Quarter 2018 Earnings Webcast BlueLinx Second Quarter 2018 Earnings Webcast Notes To Investors Forward-Looking Statements. This presentation includes forward-looking statements within the meaning of the Private Securities Litigation

More information

Financial Objectives. Forward Looking Statements. Symantec 2012 Financial Analyst Day 5/24/2012. James Beer. EVP & Chief Financial Officer

Financial Objectives. Forward Looking Statements. Symantec 2012 Financial Analyst Day 5/24/2012. James Beer. EVP & Chief Financial Officer Financial Objectives James Beer EVP & Chief Financial Officer 1 Forward Looking Statements This presentation contains statements regarding our projected financial and business results, which may be considered

More information

3 rd Quarter 2018 Financial Results

3 rd Quarter 2018 Financial Results 3 rd Quarter 2018 Financial Results Earnings Conference Call and Webcast 1 Safe Harbor Statement This report contains forward-looking statements within the meaning of the Private Securities Litigation

More information

Cautionary Note Regarding Forward Looking Statements

Cautionary Note Regarding Forward Looking Statements If(we) Acquisition Cautionary Note Regarding Forward Looking Statements Certain statements in this presentation are forward-looking statements within the meaning of the Private Securities Litigation Reform

More information

Forward Guidance. Priceline.com issued the following guidance for the 2nd half of 2004:

Forward Guidance. Priceline.com issued the following guidance for the 2nd half of 2004: Priceline.com Reports 2nd Quarter 2004 Financial Results; Gross Travel Bookings Are $470.4 Million, Up 58% Year Over Year; Airline Ticket Unit Bookings Grow 60% NORWALK, Conn.--(BUSINESS WIRE)--Aug. 2,

More information

Jefferies 2015 Global Healthcare Conference June 3, 2015

Jefferies 2015 Global Healthcare Conference June 3, 2015 Jefferies 2015 Global Healthcare Conference June 3, 2015 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act

More information

Logitech. July 24, 2013

Logitech. July 24, 2013 Logitech Q1 Fiscal Year 2014 July 24, 2013 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the federal securities laws, including, without limitation,

More information

FY2015 Results Presentation CEO & Managing Director - Julian Ogrin CFO - Leanne Wolski

FY2015 Results Presentation CEO & Managing Director - Julian Ogrin CFO - Leanne Wolski FY2015 Results Presentation CEO & Managing Director - Julian Ogrin CFO - Leanne Wolski 21 August 2015 Important notice and disclaimer This presentation includes information about the activities of amaysim

More information

Cowen and Company 34 th Annual Health Care Conference

Cowen and Company 34 th Annual Health Care Conference Cowen and Company 34 th Annual Health Care Conference March 3, 2014 Forward-Looking Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements

More information

CONFERENCE CALL 2015 RESULTS. Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY

CONFERENCE CALL 2015 RESULTS. Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY CONFERENCE CALL 205 RESULTS Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY www.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains forward-looking statements that

More information

Baxalta Incorporated. Third Quarter 2015 Financial Results Prepared Remarks

Baxalta Incorporated. Third Quarter 2015 Financial Results Prepared Remarks Baxalta Incorporated Third Quarter 2015 Financial Results Prepared Remarks Introduction: Mary Kay Ladone Good morning and welcome to the third quarter 2015 earnings conference call for Baxalta Incorporated.

More information

Windstream Reports First-Quarter Earnings Results

Windstream Reports First-Quarter Earnings Results Windstream Reports First-Quarter Earnings Results Generates $216 million in pro forma adjusted free cash flow and a dividend payout ratio of 51 percent Produces $393 million in business services revenues,

More information

Investor Overview Q Slides updated as of July 31, 2018

Investor Overview Q Slides updated as of July 31, 2018 Investor Overview Q2 2018 Slides updated as of July 31, 2018 Safe Harbor and Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of federal securities laws,

More information

Everyday Health. Investor Call December 5, 2016

Everyday Health. Investor Call December 5, 2016 Everyday Health Investor Call December 5, 2016 Safe Harbor for Forward-Looking Statements Certain statements in this presentation are forward-looking statements within the meaning of the Private Securities

More information

FY2015 Third Quarter Earnings Call

FY2015 Third Quarter Earnings Call FY2015 Third Quarter Earnings Call MARCH 20, 2015 Forward-Looking Statement Forward-looking statements in this communication regarding our expected earnings performance and all other statements that are

More information

Lisa McKnight. Barbie brand leader

Lisa McKnight. Barbie brand leader Forward-Looking Statements/Regulation G FORWARD-LOOKING STATEMENTS: This presentation contains a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act

More information

Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q

Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q Copyright 2013 Quintiles Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements

More information

Investor Relations Presentation. September 2014

Investor Relations Presentation. September 2014 Investor Relations Presentation September 2014 Forward Looking Statements This presentation contains historical information and forward-looking statements within the meaning of The Private Securities Litigation

More information

Richard Dickson. President & COO Mattel. 3_Analyst_Richard_Dickson_Presentation

Richard Dickson. President & COO Mattel. 3_Analyst_Richard_Dickson_Presentation Forward-Looking Statements/Regulation G FORWARD-LOOKING STATEMENTS: This presentation contains a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act

More information

ready for change? REVENUE RECOGNITION Private Equity and their Portfolio Companies

ready for change? REVENUE RECOGNITION Private Equity and their Portfolio Companies ready for change? REVENUE RECOGNITION Private Equity and their Portfolio Companies Are you ready for principles-based revenue recognition? THE NEW GUIDANCE PROVIDES A PRINCIPLES-BASED, FIVE-STEP PROCESS

More information

R1 to Acquire Intermedix and Selected as RCM Services Provider for Ascension Physician Business

R1 to Acquire Intermedix and Selected as RCM Services Provider for Ascension Physician Business R1 to Acquire Intermedix and Selected as RCM Services Provider for Ascension Physician Business Investor Presentation February 26, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation

More information

Revenue recognition. Resource guide for private equity and their portfolio companies. plantemoran.com

Revenue recognition. Resource guide for private equity and their portfolio companies. plantemoran.com Revenue recognition Resource guide for private equity and their portfolio companies plantemoran.com Contents Are you ready for principles-based revenue recognition? 1 Pre-deal considerations 2 Post-deal

More information

TCS Financial Results

TCS Financial Results TCS Financial Results Quarter I FY 2016-17 July 14, 2016 1 Copyright 2014 Tata Consultancy Services Limited Disclaimer Certain statements in this release concerning our future prospects are forward-looking

More information

Fresenius makes excellent start to 2018, with strong sales and net income growth in constant currency

Fresenius makes excellent start to 2018, with strong sales and net income growth in constant currency Investor News Markus Georgi Senior Vice President Investor Relations Fresenius SE & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg Germany T +49 6172 608-2485 F +49 6172 608-2488 markus.georgi@fresenius.com

More information

Linde plc Investor Update

Linde plc Investor Update Linde plc Investor Update March 1 st 2019 Making our world more productive Forward Looking Statement Linde plc has not yet completed the preparation of its financial statements for the fiscal year ended

More information

F5 to Acquire NGINX. March 11, 2019

F5 to Acquire NGINX. March 11, 2019 F5 to Acquire NGINX March 11, 2019 All rights reserved. F5, F5 Networks, and the F5 logo are trademarks of F5 Networks, Inc. in the U.S. and in certain other countries. Other F5 trademarks are identified

More information

1Q Fiscal 2019 ADP Earnings Call & Webcast

1Q Fiscal 2019 ADP Earnings Call & Webcast 1Q Fiscal 2019 ADP Earnings Call & Webcast October 31, 2018 Forward Looking Statements This presentation and other written or oral statements made from time to time by ADP may contain forward-looking statements

More information

Quarterly Financial Report of Fresenius Group

Quarterly Financial Report of Fresenius Group Quarterly Financial Report of Fresenius Group applying International Financial Reporting Standards (IFRS) 1 st Quarter 2015 2 TABLE OF CONTENTS 3 Fresenius Group figures at a glance 5 Fresenius share 6

More information

For personal use only

For personal use only ACN 166 025 047 UPDATED PRO-FORMA STATEMENT OF FINANCIAL POSITION RAISING DATED: 20 MAY 2014 PRO FORMA CONSOLIDATED STATEMENT OF FINANCIAL POSITION The following pro forma consolidated statement of financial

More information

WILLIAM BLAIR GROWTH STOCK CONFERENCE. June 14, 2017

WILLIAM BLAIR GROWTH STOCK CONFERENCE. June 14, 2017 WILLIAM BLAIR GROWTH STOCK CONFERENCE June 14, 2017 Safe Harbor Statement Statements made in this presentation which are not statements of historical fact are forward-looking statements and are subject

More information

Company Overview. August 2015

Company Overview. August 2015 Company Overview August 2015 1 Safe Harbor Forward-Looking Statements This presentation contains forward-looking statements, within the meaning of the safe harbor provisions of the Private Securities Litigation

More information

LEVERAGING OUR BIOLOGICS EXPERTISE IN BIOSIMILARS SCOTT FORAKER VICE PRESIDENT AND GENERAL MANAGER, BIOSIMILARS

LEVERAGING OUR BIOLOGICS EXPERTISE IN BIOSIMILARS SCOTT FORAKER VICE PRESIDENT AND GENERAL MANAGER, BIOSIMILARS LEVERAGING OUR BIOLOGICS EXPERTISE IN BIOSIMILARS SCOTT FORAKER VICE PRESIDENT AND GENERAL MANAGER, BIOSIMILARS SAFE HARBOR STATEMENT This presentation contains forward-looking statements that are based

More information

8x8, Inc. (NYSE:EGHT) Fourth Quarter and Full-Year Fiscal 2018 Earnings. May 24, 2018

8x8, Inc. (NYSE:EGHT) Fourth Quarter and Full-Year Fiscal 2018 Earnings. May 24, 2018 8x8, Inc. (NYSE:EGHT) Fourth Quarter and Full-Year Fiscal 2018 Earnings May 24, 2018 Forward Looking Statements This presentation includes forward-looking statements within the meaning of the Private Securities

More information

TECHNOLOGY INNOVATION SOLUTIONS. Investor Presentation

TECHNOLOGY INNOVATION SOLUTIONS. Investor Presentation Investor Presentation August 2015 Forward-looking Statements & Non-GAAP Financial Information Forward-Looking Language This presentation and all publicly available documents, including the documents incorporated

More information

Windstream Reports Second-Quarter Earnings Results

Windstream Reports Second-Quarter Earnings Results Windstream Reports Second-Quarter Earnings Results Updates financial guidance for acquisition of Iowa Telecom; raises outlook for adjusted free cash flow - expects $770 million to $810 million for full

More information

IBM REPORTS 2011 SECOND-QUARTER RESULTS

IBM REPORTS 2011 SECOND-QUARTER RESULTS IBM REPORTS 2011 SECOND-QUARTER RESULTS o Diluted EPS: - GAAP: $3.00, up 15 percent; - Operating (non-gaap): $3.09, up 18 percent; o Revenue: $26.7 billion, up 12 percent, up 5 percent adjusting for currency;

More information

2017 EARNINGS PRESENTATION PeerStream, Inc. Ticker: PEER

2017 EARNINGS PRESENTATION PeerStream, Inc. Ticker: PEER 2017 EARNINGS PRESENTATION PeerStream, Inc. Ticker: PEER safe harbor This presentation is for discussion purposes only. Certain material is based upon third party information that we consider reliable,

More information

3Q18 Financial Results. November 8, 2018

3Q18 Financial Results. November 8, 2018 3Q18 Financial Results November 8, 2018 Disclaimer No Offer or Solicitation This presentation is provided for informational purposes only and is not intended to and shall not constitute an offer to sell

More information

Glu Mobile Inc. Q Earnings Call

Glu Mobile Inc. Q Earnings Call Glu Mobile Inc. Q1 2017 Earnings Call May 3, 2017 Glu Mobile Inc. Q1 2017 Earnings Call Glu Mobile Inc. Proprietary Page 1 Safe Harbor Statement This presentation contains "forward-looking" statements

More information

Fresenius Investor News

Fresenius Investor News health care worldwide October 31, 2006 Contact: Birgit Grund Fresenius AG Investor Relations Tel. ++49-6172 - 608 2485 Fax ++49-6172 - 608 2488 e-mail: ir-fre@fresenius.de Internet: www.fresenius-ag.com

More information

We help build companies of the future

We help build companies of the future March 2018 Investor Presentation We help build companies of the future By Pat Goepel SAFE HARBOR STATEMENT (Under the Private Securities Litigation Reform Act of 1995) Statements made in this presentation

More information

Investor Update Q Rob LoCascio CEO Dan Murphy CFO

Investor Update Q Rob LoCascio CEO Dan Murphy CFO Investor Update Q4 2017 Rob LoCascio CEO Dan Murphy CFO Safe Harbor Provision Statements in this presentation regarding LivePerson that are not historical facts are forward-looking statements and are subject

More information

INVESTOR PRESENTATION THIRD QUARTER 2016 SAJAN.COM PUBLIC DOCUMENT SAJAN, INC NASDAQ: SAJA

INVESTOR PRESENTATION THIRD QUARTER 2016 SAJAN.COM PUBLIC DOCUMENT SAJAN, INC NASDAQ: SAJA INVESTOR PRESENTATION THIRD QUARTER 2016 SAFE HARBOR The Private Securities Litigation Reform Act of 1995 provides a safe harbor from liability for certain forward-looking statements. This presentation

More information

Investor Presentation RBC Capital Markets Global Healthcare Conference February 22, 2017

Investor Presentation RBC Capital Markets Global Healthcare Conference February 22, 2017 Investor Presentation 2017 RBC Capital Markets Global Healthcare Conference February 22, 2017 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private

More information